Bruce E Birkby, MD | |
500 Merrimack St, Riverwalk, Lawrence, MA 01843-1756 | |
(978) 557-8900 | |
(978) 557-8944 |
Full Name | Bruce E Birkby |
---|---|
Gender | Male |
Speciality | Allergy & Immunology |
Location | 500 Merrimack St, Lawrence, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932103298 | NPI | - | NPPES |
30004117 | Other | NH | NH MEDICAID |
3066533 | Medicaid | MA | |
A66532 | Other | NV | ANTHEM BLUE CROSS |
4374789 | Other | AETNA - NON-HMO | |
67889 | Other | HEALTHSOURCE | |
02-00098 | Other | EVERCARE | |
049426 | Other | MA | TUFTS HEALTH PLAN |
1216 | Other | MA | HARVARD PILGRIM HEALTHCAR |
1932103298 | Other | AETNA - HMO | |
6287992 | Other | CIGNA HEALTHCARE | |
J06948 | Other | MA | BLUE CROSS BLUE SHIELD |
030004806 | Other | RAILROAD MEDICARE | |
978456 | Other | NETWORK HEALTH | |
0012018 | Other | NEIGHBORHOOD HEALTH PLAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 49426 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bruce E Birkby, MD 500 Merrimack St, Riverwalk, Lawrence, MA 01843-1756 Ph: (978) 557-8900 | Bruce E Birkby, MD 500 Merrimack St, Riverwalk, Lawrence, MA 01843-1756 Ph: (978) 557-8900 |
News Archive
Scientists involved in a field campaign are away from their normal routines, offices and universities, including the support mechanisms available if sexual harassment or other inappropriate behaviors occur.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").
High clinical development costs coupled with declining drug discovery success rates are causing productivity levels to fall in the global pharmaceuticals industry. The imminent patent expiry of several major blockbuster drugs and the related rise of cheaper generic alternatives is further exacerbating the situation.
The commonly used diabetes drug metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease, according to a study at the University of Dundee.
› Verified 2 days ago
Dr. Bryan D Stone, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 500 Merrimack St, Riverwalk, Lawrence, MA 01843 Phone: 978-557-8900 Fax: 978-557-8944 |